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Abstract
Background: We aimed to evaluate the impact of thrombus aspiration (TA) during primary percutaneous coronary
intervention (P-PCI) in ‘real-world’ settings.
Methods: We performed a retrospective study, using data from the National Registry of Interventional Cardiology
(RNCI 2006–2012, Portugal) with ST-elevation myocardial infarction (STEMI) patients treated with P-PCI. The primary
outcome, in-hospital mortality, was analysed through adjusted odds ratio (aOR) and 95% confidence intervals (95%CI).
Results: We assessed data for 9458 STEMI patients that undergone P-PCI (35% treated with TA). The risk of in-hospital
mortality with TA (aOR 0.93, 95%CI:0.54–1.60) was not significantly decreased. After matching patients through the
propensity score, TA reduced significantly the risk of in-hospital mortality (OR 0.58, 95%CI:0.35–0.98; 3500 patients).
Conclusions: The whole cohort data does not support the routine use of TA in P-PCI, but the results of the propensity-
score matched cohort suggests that the use of selective TA may improve the short-term risks of STEMI.
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Background
The impact of thrombus aspiration (TA) during primary
percutaneous coronary intervention (P-PCI) has been
widely discussed in the recent years. The removal of the
thrombus before stent deployment has shown to im-
prove myocardial blush grade [1], but evidence has been
heterogeneous regarding pragmatic outcomes, namely
mortality. Survival benefits were previously supported by
the TAPAS trial [1], as well as subsequent meta-analyses
[2], including of patient level meta-analysis [3]. Both
European and American guidelines for the management
of patients with ST-Elevation Myocardial Infarction
(STEMI) recommended that routine TA should be con-
sidered, based on evidence of moderate robustness
(Class IIa, level of evidence B) [4, 5]. However, the re-
sults of larger trials did not show significant improve-
ments in the mortality. Moreover, the existing evidence
does not exclude the possibility of TA benefit in high-
risk patients or in selected cases.
We intended to assess the impact of TA outside of the
randomized controlled trial setting, to evaluate whether
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the findings of randomized controlled trials (RCTs) are
similar to those occurring in the ‘real-world’.
Methods
Data was retrieved from the Registo Nacional de Cardio-
logia de Intervenção (RNCI, Portuguese Registry on
Interventional Cardiology) between January 2006 and
December 2012 [6].
This is a continuous, prospective and observational
registry, which includes all consecutive patients under-
going coronary angiography in multiple centers with
interventional cardiology. Until December 2012 there
were overall 58,434 procedures registered.
All included patients gave informed consent for the
intervention and data collection for CNCDC (Centro
Nacional de Colecção de Dados em Cardiologia from
the Portuguese Society of Cardiology; http://www.spc.pt/
CNCDC/) and the registry procedures are in accordance
with the rules of CNPD (Comissão Nacional de Protecc-
ção de Dados – National Committee of Data Protection;
https://www.cnpd.pt/). The registry was approved by the
Portuguese Society of Cardiology ethics committee and
local ethics committees.
Inclusion criteria was P-PCI within less than 12 h of
symptom in the context of persistent (> 30 min) ST-
segment elevation or new left bundle branch block [7–9].
Exclusion criteria were facilitated and rescue PCI as well
stable coronary disease and non-ST elevation acute coron-
ary syndromes.
Patients were stratified in two groups per the presence
or absence of TA in the index procedure. TA was per-
formed at the discretion of the operator. Demographic,
clinical, patient management-related characteristics, as
well as clinical outcomes were assessed.
Our primary outcome was all-cause mortality during
the index hospitalization.
The risk was determined by odds ratio (OR) and 95%
confidence intervals (CIs) were calculated for the pri-
mary outcome. Differences between patients treated with
both TA and P-PCI, and those with PCI-PCI alone were
adjusted through multivariable regression analysis.
All demographic information, comorbidities and TIMI
flow pre-PCI data were included in a multivariable logis-
tic regression to estimate a propensity score for the like-
lihood of being treated with thrombus aspiration.
Matching was performed in a 1:1 fashion using with a 0.
05 calliper width of the propensity score [10].
The analyses were further adjusted to residual con-
founding through multivariable logistics regression, to
derive adjusted OR and 95%CIs. Statistical analyses were
performed with SPSS version 19.0 (SPSS Inc., Chicago,
IL, USA).
Results
A total of 9458 procedures fulfilled the inclusion criteria
and 35% of them had adjunctive thrombus aspiration.
Time trends show that this procedure had been increas-
ing overtime (Fig. 1).
In the whole cohort, patients treated with TA were over-
all younger and had lower proportion of cardiovascular
risk factors, with exception of smoking, as well as lower
proportion of major comorbidities (Table 1). Patients in
the group of TA had more frequently a left anterior de-
scending artery occlusion. In the patients with TA the ra-
dial access was more common than other accesses, as well
as stenting and use of GpIIbIIIa inhibitors (Table 1).
The overall in-hospital mortality was non-significantly
lower (2.2% vs 2.8%) in the TA group (Fig. 2). Differ-
ences between important baseline characteristics were
adjusted to confounders and the estimate of TA impact
on mortality remained non-significant (OR 0.93, 95%CI
0.54–1.60, p = 0.79) (Fig. 2).
The stroke rate was low and thrombus aspiration was
unlikely to affect its risk in our cohort (TA + P-PCI vs.
P-PCI: 0.1% vs. 0.2%, p = 0.77).
We conducted a sub-analysis among the 7.692 patients
that full fielded the inclusion criteria and had full infor-
mation about the TIMI flow of coronary arteries.
Fig. 1 The trend of use of thrombus aspiration in Portugal from 2006 to 2012
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Table 1 Clinical characteristics of included patients according to the use of thrombus aspiration during P-PCI
Before Matching After Matching
Thrombus aspiration and P-PCI
(n = 3311)
P-PCI only (n = 6247) p-value Thrombus aspiration and P-PCI
(n = 1750)
P-PCI only (n = 1750) p-value
Age 60 ± 13 63 ± 13 < 0.001 61 ± 13 60 ± 13 0.10
Male 77.4% 74.6% 0.002 77.7% 78.6% 0.59
Risk factors
Dyslipidemia 44.7% 44.6% 0.95 45.0% 46.2% 0.50
DM 18.7% 24.0% < 0.001 19.0% 18.9% 0.93
Smoking 43.1% 36.4% < 0.001 41.8% 45.0% 0.38
Hypertension 53.3% 59.7% < 0.001 54.1% 54.5% 0.87
Previous history
MI 11.3% 14.2% < 0.001 12.1% 12.3% 0.84
PCI 12.3% 14.0% 0.035 12.9% 13.8% 0.46
CABG 1.3% 1.7% 0.188 1.3% 1.1% 0.64
Stroke 3.9% 5.2% 0.009 4.0% 4.1% 1.00
PAD 1.9% 3.1% 0.002 1.9% 1.9% 1.00
HF 0.9% 1.9% < 0.001 0.8% 0.6% 0.69
CKD 3.2% 3.4% 0.56 3.7% 4.6% 0.21
Admission
KK IV class 6.3% 6.6% 0.57 7.3% 6.4% 0.43
Infarction-related artery
LM 1.0% 1.3% 0.20 3.6% 3.5% 0.86
LAD 42.4% 35.7% < 0.001 69.1% 69.4% 0.86
Circumflex 13.4% 17.5% < 0.001 39.5% 46.8% < 0.001
RCA 42.8% 45.1% 0.03 58.8% 57.3% 0.36
Radial access 40.2% 22.9% < 0.001 40.3% 20.3% < 0.001
Stenting / DES 79.4% / 47.5% 75.9% / 50.9% < 0.001 91.6% / 45.4% 90.9% / 46.9% 0.50 / 0.40
GpIIb/IIIa 36.9% 18.9% < 0.001 51.9% 31.0% < 0.001
CABGCoronary artery bypass graft, CKD Chronic kidney disease, DES Drug-eluting stent, DM Diabetes Mellitus, HF heart failure, KK Killip-Kimball, LAD Left Anterior
Descending Artery, LM Left Main Artery, MI Myocardial infarction, PAD peripheral artery disease, PCI angioplasty/percutaneous coronary intervention, P-PCI Primary
angioplasty. RCA Right Coronary Artery, TA Thrombus aspiration
Fig. 2 Risk of in-hospital mortality with thrombus aspiration in the whole cohort and in the propensity score matched cohort
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Patients with TA had more frequently post-PCI TIMI
flow< 3 compared to those without TA (14.0% vs.10.6%).
After propensity score matching, 1750 patients
remained in each group. The details of patients’ charac-
teristics are depicted in Table 1. The risk of in-hospital
mortality was significantly increased (OR 0.65, 95%CI 0.
43–0.97, p = 0.03), and remained after the multivariable
logistic regression (OR 0.58, 95%CI 0.35–0.98, p = 0.04)
(Fig. 2).
Discussion
This data based on a large real-world prospective regis-
try, showed that TA decreased the risk of mortality
among patients with STEMI that underwent P-PCI after
matching the patients’ characteristics for the likelihood
of being treated with TA. In Portugal we observed an in-
crease in the use of TA but more than 50% of P-PCI
evaluated were performed without this technique. It is
possible that in some case TA was used as a bail-out
procedure because the use of inhibitors of GpIIbIIIa was
higher in the TA group. Our results are distinct from
those obtained in largest RCTs, the TASTE and TOTAL
trials [11, 12]. Despite the matching and the multivari-
able adjustments, our data is still retrospective, under-
powered and with possible residual cofounding bias.
Improving the microvascular perfusion in patients
with STEMI is attractive, particularly when large macro-
scopic thrombi are retrieved. It provides the feeling that
operators interfere directly with the pathophysiologic
mechanics and improve the prognostic of patients. The
RCT data show that routine thrombus aspiration does
not seem to influence the mortality of patients with
STEMI. However, our data suggests that ‘selective’ TA
may be useful to improve outcomes in patients with
STEMI. The recognition of the type of patients in which
TA is likely to be successful may be the key to the ob-
tained results.
Due to limited data accuracy for other outcomes, our
study only covered the in-hospital mortality. Similarly to
the results regarding the short-term outcomes, the major
trials also showed that TA did not improve 1-year out-
comes [13, 14]. The results of observational data are het-
erogeneous. In a cohort with more than 10,000 patients
with STEMI (about 3500 of STEMI patients treated with
TA and P-PCI), TA did not show improvement in the
risk of mortality [15]. Inversely, other observational
studies showed that a ‘selective’ TA in P-PCI can im-
prove outcomes, mortality included [16, 17]. The best
available evidence, based on RCTs, is robust for not
using ‘routinely’ the TA in P-PCI but do not preclude
the use of TA in selected cases, as occurs with other in-
terventions available for acute cardiac care setting [18].
In this cohort the rates of stroke were very low, and
no differences were found between the groups, despite
the cumulative evidence regarding this adverse event
which is known to have a small increase in the absolute
risk with TA [19].
Limitations
Our results are limited because this is a consecutive all-
comers procedural registry that has inherently limita-
tions due to the lack of randomization and blinding ef-
fect. Despite the adjustment to multiple clinical and
angiographic characteristics, it is worth noting that the
data may not adjust to all potential confounders and
thus increase the risk of bias in the analyses. The pro-
pensity score matching partially improves some of these
limitations. However, this matching occurs with a de-
crease of the sample size which increases the risk of type
II errors [20, 21]. Unfortunately, there are no data re-
garding the types of devices used in the TA as well as
additional details of operators and procedures, which
also hampers the conclusions.
Conclusion
The use of thrombus aspiration did not have a signifi-
cant impact in the short-term prognosis of STEMI pa-
tients that underwent primary percutaneous coronary
intervention in the whole cohort. The results of the
propensity-score matched cohort suggests a potential
role for selective thrombus aspiration.
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